| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Personal Care | | | | 580.7 | 490.9 | 426.0 | | |
| Hospice | | | | 53.6 | 18.9 | | | |
| Home Health | | | | 14.5 | 6.9 | | | |
| Total revenues | 951.1 | 864.5 | 764.8 | 648.8 | 516.6 | 426.0 | 400.9 | 336.8 |
| Revenue growth [+] | 10.0% | 13.0% | 17.9% | 25.6% | 21.3% | 6.3% | 19.0% | 7.6% |
| Personal Care | | | | 18.3% | 15.2% | | | |
| Hospice | | | | 184.4% | | | | |
| Home Health | | | | 110.9% | | | | |
| Cost of goods sold | 651.4 | 594.7 | 538.5 | 469.6 | 379.8 | 310.1 | 294.6 | 245.5 |
| Gross profit | 299.7 | 269.8 | 226.2 | 179.2 | 136.8 | 115.9 | 106.3 | 91.3 |
| Gross margin | 31.5% | 31.2% | 29.6% | 27.6% | 26.5% | 27.2% | 26.5% | 27.1% |
| Selling, general and administrative [+] | 96.4 | 87.5 | 80.0 | 195.3 | 160.7 | 118.1 | 115.8 | 66.1 |
| General and administrative | 96.4 | 87.5 | 80.0 | 195.3 | 160.7 | 118.1 | 115.8 | 66.1 |
| Other operating expenses | 365.6 | 320.3 | 283.4 | -61.4 | -55.3 | -34.2 | -39.5 | 4.4 |
| EBITDA [+] | -148.2 | -123.5 | -125.2 | 45.3 | 31.5 | 31.9 | 30.1 | 20.7 |
| EBITDA growth | 20.0% | -1.4% | -376.2% | 44.0% | -1.4% | 6.0% | 45.2% | -5.3% |
| EBITDA margin | -15.6% | -14.3% | -16.4% | 7.0% | 6.1% | 7.5% | 7.5% | 6.2% |
| Depreciation | 6.9 | 6.0 | 5.0 | 4.0 | 2.4 | 2.0 | 1.7 | 1.7 |
| EBITA | -155.1 | -129.5 | -130.1 | 41.4 | 29.0 | 30.0 | 28.4 | 19.0 |
| EBITA margin | -16.3% | -15.0% | -17.0% | 6.4% | 5.6% | 7.0% | 7.1% | 5.6% |
| Amortization of intangibles | 7.2 | 8.5 | 7.1 | 6.6 | 6.2 | 4.7 | 4.9 | 3.0 |
| EBIT [+] | -162.3 | -138.0 | -137.2 | 34.8 | 22.8 | 25.3 | 23.5 | 16.0 |
| EBIT growth | 17.6% | 0.5% | -494.9% | 52.2% | -9.6% | 7.6% | 46.5% | -11.3% |
| EBIT margin | -17.1% | -16.0% | -17.9% | 5.4% | 4.4% | 5.9% | 5.9% | 4.8% |
| Non-recurring items [+] | | | | | | | 8.0 | |
| Asset impairment | | | | | | | 8.0 | |
| Interest expense, net [+] | -0.3 | -0.3 | -0.6 | 1.6 | 2.4 | 4.4 | -0.5 | 0.7 |
| Interest expense | 8.9 | 5.8 | 3.2 | 3.1 | 5.0 | 4.5 | 2.3 | 0.8 |
| Interest income | 0.3 | 0.3 | 0.6 | 1.5 | 2.6 | 0.1 | 2.8 | 0.0 |
| Other income (expense), net [+] | 231.0 | 203.9 | 181.7 | | | 0.2 | 0.2 | |
| Gain (loss) on sale of business | | | | | | 2.5 | | |
| Other non-operating income | | | | | | 0.2 | 0.2 | |
| Other | | | | | | 0.2 | -0.2 | |
| Pre-tax income | 60.2 | 60.4 | 41.9 | 33.2 | 20.4 | 21.1 | 16.2 | 15.3 |
| Income taxes | 14.1 | 15.3 | 8.8 | 7.4 | 4.1 | 9.3 | 4.1 | 3.9 |
| Tax rate | 23.5% | 25.3% | 21.0% | 22.2% | 20.1% | 44.0% | 25.4% | 25.7% |
| Net income | 46.0 | 45.1 | 33.1 | 25.8 | 16.3 | 11.8 | 12.1 | 11.4 |
| Net margin | 4.8% | 5.2% | 4.3% | 4.0% | 3.2% | 2.8% | 3.0% | 3.4% |
| |
| Basic EPS [+] | $2.90 | $2.87 | $2.12 | $1.87 | $1.35 | $1.03 | $1.07 | $1.03 |
| Growth | 1.2% | 35.0% | 13.7% | 38.0% | 31.5% | -3.6% | 3.4% | -5.8% |
| Diluted EPS [+] | $2.84 | $2.81 | $2.08 | $1.81 | $1.32 | $1.02 | $1.06 | $1.01 |
| Growth | 1.3% | 35.3% | 14.6% | 37.6% | 29.6% | -4.4% | 4.8% | -5.7% |
| |
| Shares outstanding (basic) [+] | 15.9 | 15.7 | 15.6 | 13.8 | 12.0 | 11.5 | 11.3 | 11.0 |
| Growth | 0.8% | 0.9% | 12.9% | 14.7% | 5.0% | 1.6% | 2.8% | 0.8% |
| Shares outstanding (diluted) [+] | 16.2 | 16.1 | 16.0 | 14.2 | 12.4 | 11.6 | 11.3 | 11.2 |
| Growth | 0.7% | 0.7% | 12.0% | 15.1% | 6.5% | 2.4% | 1.4% | 0.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |